Clinical Trials Directory

Trials / Unknown

UnknownNCT04202848

The Clinical Study of Modern Therapies on Flora in Body Fluids and Blood of Malignant Tumor Patients

Status
Unknown
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
The First Affiliated Hospital of Dalian Medical University · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers

Summary

The clinical study of modern therapies on flora changing in blood, oral cavity, urethra and intestinal tract of patients with malignant tumors. The study is observational. Patients are diagnosed cancer based on pathology or cell biology. The sample of flora will be obtained from their blood, oral cavity, urethra and intestinal tract, mainly to study what modern therapies lead to the influence of microecological environment including diversity and abundance of bacteria in patients who received malignant tumors. Immunological examination and Blood biochemistry evaluation include the number ratio, activity and function of immune cell, the immune cell marker(CD3, CD4, CD8, etc), C-reactive protein(CRP), tumor necrosis factor(TNF), Inflammatory stimulant factor(IL-2, IL-6, etc), tumor marker(CEA, AFP, etc),etc. Clinical evaluation includes image data(CT/MRI), quality of life(QOL), no disease progression survival, total survival, objective disease remission rate, etc.

Detailed description

This study collected samples of feces, urine, discarded blood and pharyngeal swab specimens from clinical laboratory from patients with malignant tumors in thoracic surgery department, general surgery department, oncology department and etc before and after treatments which contain chemotherapy, radiation therapy, immune targeted, endocrine therapy, surgery, traditional Chinese medicine and other modern therapies. Researchers will analyze the samples by oral flora, urethra, blood flora bacteria, the species diversity and abundance of the intestinal flora. Besides, quantitative analysis of inflammatory stimulators, c-reactive protein and tumor necrosis factor in peripheral blood was conducted to observe the relationship between the change characteristics of blood, oral, intestinal, urinary tract flora and urine composition caused by treatment and the therapeutic effect and prognosis.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTFlora analysisdiversity and abundance of bacteria in patients who received malignant tumors

Timeline

Start date
2019-12-20
Primary completion
2022-11-11
Completion
2022-11-11
First posted
2019-12-18
Last updated
2019-12-18

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04202848. Inclusion in this directory is not an endorsement.